GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals	38.22B	37.49B	34.54B	32.52B	32.78B
Pharmaceuticals Growth	1.93%	8.56%	6.21%	-0.80%	12.05%
Total	38.22B	37.49B	34.54B	32.52B	32.78B
Total Growth	1.93%	8.56%	6.21%	-0.80%	12.05%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	37.70B	36.99B	33.92B	31.88B	31.96B
India Growth	1.92%	9.03%	6.42%	-0.26%	9.80%
Foreign	520.95M	504.66M	614.05M	640.05M	818.97M
Foreign Growth	3.23%	-17.82%	-4.06%	-21.85%	459.67%
Total	38.22B	37.49B	34.54B	32.52B	32.78B
Total Growth	1.93%	8.56%	6.21%	-0.80%	12.05%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 19, 2026

Data Sources Report a data error